regadenoson has been researched along with Coronary Stenosis in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (10.53) | 29.6817 |
2010's | 16 (84.21) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Araujo Silva, B; Bortolotto, AL; Gervino, EV; Hauser, TH; Marum, AA; Medeiros, SA; Nearing, BD; Pedreira, GC; Tessarolo Silva, F; Verrier, RL | 1 |
Howe, C; Kumar, G; Lee, JZ; Lee, KS; Low, SW; Nguyen, T; Nyotowidjojo, I; Pinto, D; Singh, N | 1 |
Gebker, R; Hireche-Chikaoui, H; Kelle, S; Pieske, B; Schnackenburg, B; Stoiber, L | 1 |
Arai, AE; Chen, MY; Conn, HM; Greve, AM; Hsu, LY; Patricia Bandettini, W; Shanbhag, SM; Ta, AD; Winkler, S | 1 |
Bober, R; Edward, JA; Lee, JH; Morin, DP; White, CJ | 1 |
Kerut, EK; Turner, MC | 1 |
Al Badarin, F; Bateman, TM; Case, JA; Chan, PS; Courter, S; Heller, GV; Kennedy, KF; McGhie, AI; Patel, KK; Spertus, JA | 1 |
Clavijo, LC; Doherty, R; Gopal, A; Matthews, RV; Mehra, A; Prasad, A; Shavelle, DM; Somma, K; Vora, H; Zareh, M | 1 |
Dziuk, M; Kocki, J; Pińkowski, R; Tkaczewski, K | 1 |
Hakeem, A; Uretsky, B | 1 |
Brueren, GR; Lenders, GD; Pijls, NH; Schampaert, S; Tonino, PA; van 't Veer, M; van Nunen, LX; Wijnbergen, I | 1 |
Baxa, J; Ferda, J; Flohr, T; Hromádka, M; Moláček, J; Schmidt, B; Šedivý, J; Štěpánková, L | 1 |
Belardinelli, L; Dione, DP; Jadbabaie, F; Mekkaoui, C; Meoli, DF; Purushothaman, K; Sinusas, AJ | 1 |
Dilsizian, V | 1 |
Abdelmoneim, SS; Adolphson, M; Eifert-Rain, S; Erdkamp, M; Hagen, ME; High, RR; Mulvagh, SL; O'Leary, E; Olson, J; Porter, TR; Smith, LM; Wong, BF; Xie, F | 1 |
Gulati, V; Khandhar, S; Lee, JS; Marroquin, OC; Mulukutla, SR; Nair, PK; Schindler, JT | 1 |
Pijls, NH; Tonino, PA | 1 |
Bragadeesh, T; Kaul, S; Le, DE; Wang, YG; Zha, D; Zhao, Y | 1 |
Lindner, JR | 1 |
2 review(s) available for regadenoson and Coronary Stenosis
Article | Year |
---|---|
Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis.
Topics: Administration, Intravenous; Adult; Aged; Cardiac Catheterization; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Male; Middle Aged; Nitroprusside; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Severity of Illness Index; Vasodilator Agents | 2018 |
[A novel way to induce coronary hyperaemia].
Topics: Adenosine; Coronary Angiography; Coronary Stenosis; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Purines; Pyrazoles | 2013 |
3 trial(s) available for regadenoson and Coronary Stenosis
Article | Year |
---|---|
Intravenous regadenoson with aminophylline reversal is safe and equivalent to intravenous adenosine infusion for fractional flow reserve measurements.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aminophylline; Cardiotonic Agents; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Infusions, Intravenous; Male; Middle Aged; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Vasodilator Agents | 2018 |
Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Comparative Effectiveness Research; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Dipyridamole; Female; Health Status; Humans; Kansas; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardial Revascularization; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Referral and Consultation; Severity of Illness Index; Single Photon Emission Computed Tomography Computed Tomography; Time Factors; Treatment Outcome; Vasodilator Agents | 2019 |
Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement.
Topics: Aged; Cardiac Catheterization; Catheterization, Central Venous; Catheterization, Peripheral; Coronary Angiography; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Netherlands; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Vasodilator Agents | 2015 |
14 other study(ies) available for regadenoson and Coronary Stenosis
Article | Year |
---|---|
Regadenoson-induced T-wave heterogeneity complements coronary stenosis detection by myocardial perfusion imaging in men and women.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Humans; Male; Myocardial Perfusion Imaging; Purines; Pyrazoles | 2021 |
CMR stress testing in a patient with morbid obesity (BMI 58 kg/m
Topics: Body Mass Index; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Myocardial Perfusion Imaging; Obesity, Morbid; Predictive Value of Tests; Prognosis; Purines; Pyrazoles; Risk Factors; Vasodilator Agents | 2018 |
Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis.
Topics: Adult; Aged; Artifacts; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Vasodilator Agents | 2018 |
Coronary "balanced ischemia" with false negative regadenoson Technetium Tc99 m Sestamibi stress test subsequently diagnosed by FFR
Topics: Adenosine A2 Receptor Agonists; Computed Tomography Angiography; Coronary Angiography; Coronary Stenosis; Diagnosis, Differential; Exercise Test; False Negative Reactions; Female; Fractional Flow Reserve, Myocardial; Humans; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Stents; Technetium Tc 99m Sestamibi | 2018 |
Use of regadenoson for measurement of fractional flow reserve.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Cardiac Catheterization; Coronary Angiography; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Predictive Value of Tests; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Severity of Illness Index; Vasodilator Agents | 2014 |
Regadenoson for FFR: time to say good-bye to adenosine?
Topics: Adenosine; Adenosine A2 Receptor Agonists; Cardiac Catheterization; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Purines; Pyrazoles; Vasodilator Agents | 2014 |
Regadenoson-Stress Dynamic Myocardial Perfusion Improves Diagnostic Performance of CT Angiography in Assessment of Intermediate Coronary Artery Stenosis in Asymptomatic Patients.
Topics: Blood Pressure; Coronary Angiography; Coronary Stenosis; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Tomography, X-Ray Computed | 2015 |
Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dogs; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Connectivity of radiotracers to vasodilators is thallium the missing link?
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Dogs; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress.
Topics: Aged; Cohort Studies; Contrast Media; Coronary Angiography; Coronary Stenosis; Echocardiography, Stress; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Observer Variation; Perfusion; Purines; Pyrazoles; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Time Factors | 2011 |
Clinical utility of regadenoson for assessing fractional flow reserve.
Topics: Adenosine A2 Receptor Antagonists; Aged; Aged, 80 and over; Coronary Angiography; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Purines; Pyrazoles; Statistics as Topic; Stroke Volume; Vasodilation; Ventricular Function, Left | 2011 |
The crux of maximum hyperemia: the last remaining barrier for routine use of fractional flow reserve.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Coronary Stenosis; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Purines; Pyrazoles; Vasodilator Agents | 2011 |
Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Aorta; Coronary Stenosis; Echocardiography; Heart Rate; Hemodynamics; Humans; Myocardial Perfusion Imaging; Myocardium; Purines; Pyrazoles; Stroke Volume; Vasodilator Agents; Ventricular Function, Left | 2012 |
Perfusion imaging with vasodilator stress echocardiography: a physiologically sound approach to coronary disease?
Topics: Coronary Stenosis; Echocardiography, Stress; Female; Humans; Male; Perfusion; Purines; Pyrazoles | 2011 |